Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo S Plantinga

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort studyMelissa D Johnson, Theo S Plantinga, Esther van de Vosse, et al.
Nature Communications|September 9, 2014
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemiaVinod Kumar, Shih-Chin Cheng, Melissa D Johnson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 13, 2015
The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infectionsMartin Jaeger, Robin van der Lee, Shih-Chin Cheng, et al.
The Journal of Clinical Investigation|November 2, 2013
CX3CR1-dependent renal macrophage survival promotes Candida control and host survivalMichail S Lionakis, Muthulekha Swamydas, Brett G Fischer, et al.
Nature Communications|January 10, 2013
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicansSanne P Smeekens, Aylwin Ng, Vinod Kumar, et al.
The New England Journal of Medicine|October 30, 2009
Human dectin-1 deficiency and mucocutaneous fungal infectionsBart Ferwerda, Gerben Ferwerda, Theo S Plantinga, et al.
Molecular Cancer Therapeutics|June 30, 2026
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability TradeoffsLouise A Koopman, Farshid Alemdehy, Stefanie A H de Poot, et al.
Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.
Nature Communications|February 15, 2017
A genome-wide association study yields five novel thyroid cancer risk lociJulius Gudmundsson, Gudmar Thorleifsson, Jon K Sigurdsson, et al.
Nature Genetics|January 24, 2012
Discovery of common variants associated with low TSH levels and thyroid cancer riskJulius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2011
Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort studyMelissa D Johnson, Theo S Plantinga, Esther van de Vosse, et al.
Nature Communications|September 9, 2014
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemiaVinod Kumar, Shih-Chin Cheng, Melissa D Johnson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 13, 2015
The RIG-I-like helicase receptor MDA5 (IFIH1) is involved in the host defense against Candida infectionsMartin Jaeger, Robin van der Lee, Shih-Chin Cheng, et al.
The Journal of Clinical Investigation|November 2, 2013
CX3CR1-dependent renal macrophage survival promotes Candida control and host survivalMichail S Lionakis, Muthulekha Swamydas, Brett G Fischer, et al.
Nature Communications|January 10, 2013
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicansSanne P Smeekens, Aylwin Ng, Vinod Kumar, et al.
The New England Journal of Medicine|October 30, 2009
Human dectin-1 deficiency and mucocutaneous fungal infectionsBart Ferwerda, Gerben Ferwerda, Theo S Plantinga, et al.
Molecular Cancer Therapeutics|June 30, 2026
Preclinical Comparison of Two CD3xB7H4 Bispecific Antibodies for Solid Tumor Therapy Reveals CD3 Affinity-Dependent Potency and Tolerability TradeoffsLouise A Koopman, Farshid Alemdehy, Stefanie A H de Poot, et al.
Cancer Discovery|February 17, 2022
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid TumorsAlexander Muik, Elena Garralda, Isil Altintas, et al.
Nature Communications|February 15, 2017
A genome-wide association study yields five novel thyroid cancer risk lociJulius Gudmundsson, Gudmar Thorleifsson, Jon K Sigurdsson, et al.
Nature Genetics|January 24, 2012
Discovery of common variants associated with low TSH levels and thyroid cancer riskJulius Gudmundsson, Patrick Sulem, Daniel F Gudbjartsson, et al.
Pageof 9